NDBO n=305 | DBO n=48 | GORD n=131 | Colonic polyp n=150 | Healthy n=47 | |
(1) Abdominal pains | 13.2% (39) | 9.1% (4) | 19.5% (24) | 10.1% (14) | 0.0% (0) |
p=0.208 | p=0.126 | p=0.073 | p=<0.001* | ||
(2) Heartburn | 11.2% (33) | 2.2% (1) | 31.3% (40) | 6.3% (9) | 2.1% (1) |
p=0.172 | p=<0.001* | p=0.011* | p=0.063 | ||
(3) Acid regurgitation | 10.0% (30) | 4.3% (2) | 25.2% (32) | 2.8% (4) | 0.0% (0) |
p=0.31 | p=0.001* | p=<0.001* | p=<0.001* | ||
(4) Hunger pains | 9.5% (28) | 6.7% (3) | 15.1% (19) | 2.8% (4) | 0.0% (0) |
p=0.349 | p=0.311 | p=0.013* | p=0.019* | ||
(5) Nausea | 3.7% (11) | 2.2% (1) | 7.1% (9) | 0.0% (0) | 0.0% (0) |
p=0.125 | p=<0.001* | p=0.009* | p=0.008* | ||
(6) Rumbling | 10.4% (31) | 4.7% (2) | 11.7% (15) | 8.3% (12) | 2.1% (1) |
p=0.031* | p=0.148 | p=0.187 | p=0.056 | ||
(7) Abdominal bloating | 16.6% (49) | 6.7% (3) | 18.0% (23) | 9.0% (13) | 0.0% (0) |
p=0.053 | p=0.553 | p=0.097 | p=<0.001* | ||
(8) Belching | 11.1% (33) | 6.5% (3) | 25.6% (33) | 2.1% (3) | 0.0% (0) |
p=0.63 | p=<0.001* | p=<0.001* | p=<0.001* | ||
(9) Increased flatus | 14.0% (42) | 15.2% (7) | 27.5% (36) | 8.9% (13) | 0.0% (0) |
p=0.581 | p=0.002* | p=0.417 | p=<0.001* | ||
(10) Decreased stools | 25.5% (73) | 19.1% (9) | 31.5% (40) | 21.6% (30) | 15.2% (7) |
p=0.433 | p=0.014* | p=0.771 | p=0.207 | ||
(11) Increased stools | 5.9% (17) | 8.5% (4) | 5.5% (7) | 4.3% (6) | 4.3% (2) |
p=0.193 | p=0.323 | p=0.85 | p=0.261 | ||
(12) Loose stools | 6.8% (20) | 4.4% (2) | 9.8% (12) | 6.3% (9) | 2.1% (1) |
p=0.357 | p=0.044* | p=0.391 | p=<0.001* | ||
(13) Hard stools | 9.5% (28) | 8.9% (4) | 17.1% (21) | 9.1% (13) | 0.0% (0) |
p=0.715 | p=0.004* | p=0.737 | p=0.009* | ||
(14) Urgency | 8.5% (25) | 11.1% (5) | 8.9% (11) | 7.0% (10) | 0.0% (0) |
p=0.572 | p=0.207 | p=0.752 | p=<0.001* | ||
(15) Incomplete evacuation | 10.9% (32) | 4.4% (2) | 16.3% (20) | 7.7% (11) | 2.1% (1) |
p=0.157 | p=0.049* | p=0.539 | p=0.007* |
This table compares all groups to the non-dysplastic BO cohort for each item of the GSRS. p values are derived by Fisher’s exact test.
*p values <0.05 were deemed statistically significant.
BO, Barrett’s oesophagus; DBO, dysplastic Barrett’s oesophagus; GORD, gastro-oesophageal reflux disease; GSRS, Gastrointestinal Symptom Rating Scale; NDBO, non-dysplastic Barrett’s oesophagus.